Mondelez International Inc Stock Downgraded (MDLZ)
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK (TheStreet) -- Mondelez International (Nasdaq:MDLZ) has been downgraded by TheStreet Ratings from buy to hold. The company's strengths can be seen in multiple areas, such as its increase in net income, reasonable valuation levels and good cash flow from operations. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year.
- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
- The net income growth from the same quarter one year ago has exceeded that of the S&P 500 and the Food Products industry average. The net income increased by 5.4% when compared to the same quarter one year prior, going from $976.00 million to $1,029.00 million.
- The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. Compared to other companies in the Food Products industry and the overall market on the basis of return on equity, MONDELEZ INTERNATIONAL INC has outperformed in comparison with the industry average, but has underperformed when compared to that of the S&P 500.
- MONDELEZ INTERNATIONAL INC has improved earnings per share by 5.5% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. However, we anticipate underperformance relative to this pattern in the coming year. During the past fiscal year, MONDELEZ INTERNATIONAL INC increased its bottom line by earning $1.99 versus $1.42 in the prior year. For the next year, the market is expecting a contraction of 28.1% in earnings ($1.43 versus $1.99).
- MDLZ has underperformed the S&P 500 Index, declining 24.81% from its price level of one year ago. The fact that the stock is now selling for less than others in its industry in relation to its current earnings is not reason enough to justify a buy rating at this time.
-- Written by a member of TheStreet Ratings Staff
FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.
Latest Headlines about MDLZ
-
Morning Briefing: 10 Things You Should Know
07:33AM 05/16/13
-
PepsiCo May Like Oreos Enough to Consume Mondelez
06:00AM 05/16/13
-
Bullish Two Hundred Day Moving Average Cross - MDLZ
11:47AM 05/14/13
-
'Mad Money' Lightning Round: Buy, Buy, Buy Biogen
06:00AM 05/10/13
-
Cramer's 'Mad Money' Recap: Looking for Real Leaders
08:17PM 05/09/13
-
PepsiCo, Mondelez Shares Jump on Merger Rumors
12:25PM 03/22/13
-
Cramer's 'Mad Money' Recap: It's Time to Pause
08:12PM 03/21/13
Latest from TheStreet Wire
-
Today's Stocks Driving Success For The Health Services Industry
01:03PM 05/23/13
-
CTRX, STJ, CI, TMO And BAX, Pushing Health Services Industry Downward
01:03PM 05/23/13
-
5 Stocks Underperforming Today In The Services Sector
01:03PM 05/23/13
-
3 Stocks Advancing The Energy Industry
01:03PM 05/23/13
-
4 Stocks Moving The Consumer Non-Durables Industry Upward
01:03PM 05/23/13
-
3 Stocks Dragging In The Drugs Industry
01:03PM 05/23/13
-
OI, RL, NKE And COH, 4 Consumer Non-Durables Stocks Pushing The Industry Lower
01:03PM 05/23/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
